Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001829126-26-001810·Indaptus Therapeutics, Inc.
Schedule 13D ownership disclosure
INDAPTUS THERAPEUTICS INC
Common Stock, $0.01 par value · CUSIP: 45339J105
Event date: 2026-02-26
- Filing-level shares
- 111,000,000.00
- Percent of class
- 98%
- Lazar David E.Reported CIK 0001932843
Shares: 111,000,000.00 · Class: 98%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001829126-26-001810
- Form type
- SCHEDULE 13D
- Filer
- Indaptus Therapeutics, Inc.
- CIK
- CIK 1857044
- Filed
- Mar 02, 2026
- Reporting period
- Feb 26, 2026
- Description
- Schedule 13D beneficial ownership